Tasca Therapeuticstasca

Tasca Therapeuticstasca is a private biotechnology company focused on the discovery and development of small molecule inhibitors targeting autopalmitylated proteins that play a crucial role in cancer. The company’s lead program, CP-383, is a first-in-class candidate demonstrating strong preclinical activity across multiple cancer types.